image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Judges Scientific

March 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • JDG
  • Price:
  • 9640p
Judges, the “buy-and-build” scientific instruments group, said 2023 was ‘in line’ with underlying revenues up by 15% in spite of the challenging macro economic environment and helped by easing supply chains. The organic order intake increased 7%. Recent acquisitions Geotek, Henniker and Bossa Nova Vision delivered satisfactory performances. Unchanged forecasts from Shore Capital are for eps of 368.1p in FY23 rising to 383.5p this year and 403p next. The broker cites a continued strong outlook underpinned by “secular growth factors, supported by technology development, and data, education and legal compliance standards requiring instrument investment.” I am a strong holder. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X